The global deep brain stimulation (DBS) market is expected to grow at a CAGR of around 9% during 2019-2024. The DBS is a surgical procedure that aids in treating various neurological and movement disorders such as Parkinson's disease, epilepsy, dystonia and obsessive-compulsive disorder (OCD). It involves the placement of a neurostimulator that sends continuous electrical signals to a specific part of the brain. These signals block the neurological dysfunction causing impulses and aid the brain to function more effectively. The procedure directly changes the brain’s activity but in a controlled manner and is only prescribed when medications fail to have an impact as a treatment option of any motor neuron disease.
The frequent occurrence of motor and neurological disorders, along with the growing acceptance of minimally invasive (MI) surgeries is the key factor driving the growth of the market. Addition to this, the market growth is also receiving a boost owing to the growing geriatric population, coupled with increasing awareness regarding the benefits of the DBS procedure, such as improved motor symptoms for a longer period and fewer side effects. Furthermore, the prevalence of lifestyle diseases such as obesity and hypertension-induced depression is continuously rising. The DBS is considered crucial in providing therapeutic solutions for such ailments, which is leading to its rapid adoption across the globe. Additionally, technological advancements such as the incorporation of robot-assisted implantations and multi-target stimulations, along with an increasing focus on research and development (R&D) activities to make it a completely non-invasive procedure is also providing an impetus to the market growth.
IMARC Group’s latest report provides a deep insight into the global deep brain stimulation (DBS) market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the deep brain stimulation (DBS) market in any manner.
The report has also analysed the competitive landscape of the market with some of the key players being Boston Scientific, Medtronic, St. Jude Medical, Aleva Neurotherapeutics, Beijing Pins Medical, NeuroPace, Neuro Sigma, ANM Adaptive Neuromodulation, Aleva Neurotherapeutics, etc.
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-702-409-7331 )
( India: +91-120-433-0800 )
Drop us an email at